Rogerio Manso Joins Solazyme as Chief Commercialization Officer
Global oil and gas executive with deep international experience in the sugar, oil and biofuel industry, to lead global commercialization of Solazyme’s tailored oil platform
South San Francisco, CA – July 26, 2011 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today that Rogerio Manso has joined Solazyme as its Chief Commercialization Officer. Mr. Manso will lead the commercialization of Solazyme’s tailored oil platform globally, helping to build manufacturing capacity and bring Solazyme’s products to market in Brazil, and abroad.
Mr. Manso is an experienced executive with a background in the oil and gas industry and in the accelerated deployment of a revolutionary multi-plant project in the sugar and ethanol sector in Brazil. He spent 28 years at Petrobras where he served in various leadership roles, with an accomplished record in the development of markets for Brazilian oils and oil products in the US, Europe, Latin America, Africa and Asia. He became Petrobras’ Downstream Director and a member of their Executive Committee, with responsibility over Refining and Marketing, Petrochemicals, Transportation and Logistics, where he implemented a focused multi-billion dollar refinery investment program.
Mr. Manso served as a member of the board of directors of chemical companies Petroquisa and Copesul, now a part of Braskem. He was also a member of Petrobras’ R&D Committee, of BM&FBovespa’s Sugar and Ethanol Advisory Board, Chairman of the Board of joint-venture refinery Refap S.A. and TBG, Bolivia-Brazil’s gas pipeline. After leaving Petrobras in 2007, Mr. Manso joined the start-up Brazilian Renewable Energy Company-Brenco, now a part of ETH Bioenergia, as the Executive Vice President of Commercial and Logistics, later assuming its COO role.
“Rogerio is a seasoned executive and brings an incredible set of experiences to Solazyme,” said Jonathan Wolfson, CEO, Solazyme. “He is uniquely equipped to commercialize our technology globally, and brings deep expertise in Brazil, a region of critical importance to our company. His background is an excellent fit with Solazyme’s growth strategy.”
“Solazyme’s clear technology leadership, and the broad opportunity that it presents through its tailored oils platform makes this a tremendous growth opportunity,” said Manso. “I am looking forward to working closely with the high-quality partners and the enthusiastic and knowledgeable people at Solazyme in the deployment of this disruptive sugar-to-oil technology.”
About Solazyme, Inc.
Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.
Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.
This press release contains certain forward-looking statements about Solazyme, Inc., including statements that involve risks and uncertainties concerning the future commercialization plans of Solazyme. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, Inc., that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme’s limited operating history; its ability to enter into and maintain strategic collaborations; its ability to obtain requisite regulatory approvals; and its access, on favorable terms, to any required financing. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme, Inc.
In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Registration Statement on Form S-1, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme, Inc. is not under any duty to update any of the information in this press release.
Solazyme, Inc.,Public Relations:Genet Garamendi press [at] solazyme [dot] com
The OutCast Agency, John O’Brien, 415-392-8282 solazyme [at] theoutcastagency [dot] com